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ABSTRACT 
A major remaining challenge for magnetic resonance-based attenuation correction 
methods (MRAC) is their susceptibility to sources of MRI artifacts (e.g. implants, motion) 
as well as uncertainties due to the limitations of MRI contrast (e.g. accurate bone 
delineation and density, and separation of air/bone). We propose using a Bayesian deep 
convolutional neural network that, in addition to generating an initial pseudo-CT from MR 
data, also produces uncertainty estimates of the pseudo-CT in order to quantify the 
limitations of the MR data.  These outputs are combined with an MLAA reconstruction 
that uses the PET emission data to improve the attenuation maps.  With the proposed 
approach (UpCT-MLAA), we demonstrate accurate estimation of PET uptake in pelvic 
lesions and show robust recovery of metal implants. Methods: Twenty-nine patients were 
scanned using an integrated 3 Tesla time-of-flight PET/MRI system: of the twenty-nine, 
three patients had metal implants. Helical x-ray computed tomography (CT) images of the 
twenty-six patients without implants were acquired separately. A Bayesian deep 
convolutional neural network was trained to transform Dixon MRI into pseudo-CT images 
and estimate regions of uncertainty. The pseudo-CT prior and uncertainty estimates were 
used to guide the MLAA reconstruction, updating only regions of high uncertainty. Lesions 
were identified, and the SUVmax was measured and compared against CT-based 
attenuation correction (CTAC), zero echo-time and Dixon Deep pseudo-CT (ZeDD-CT), 
and standard MLAA. Results: In patients without metal implants, UpCT-MLAA had 
acceptable but slightly higher RMSE than ZeDD-CT for bone lesions (3.4% and 2.7%, p =
0.037 respectively) and soft tissue lesions (4.8% and 4.1%, p = 0.16, respectively) when 
compared to CTAC. In patients with metal implants, standard MLAA was able to extract 
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the attenuation coefficients of the metal implant; however, the anatomy outside the 
implant region was heavily obscured by noise and cross-talk artifacts. ZeDD-CT was able 
to estimate the attenuation coefficients in normal anatomy; however, the metal implant 
was estimated to have attenuation coefficients of air due to the metal artifact appearing 
as a signal void on the MRI. UpCT-MLAA successfully estimated the attenuation 
coefficients of the metal implants while still providing qualitatively and quantitatively 
accurate anatomic depiction outside of metal implant regions. Conclusion: UpCT-MLAA 
provides accurate quantitative uptake in pelvic lesions while also demonstrating robust 
recovery of metal implants in pelvis PET/MRI. 
Keywords: Bayesian deep learning, deep learning, MLAA, MRAC, synthetic CT 
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INTRODUCTION 
The quantitative accuracy of simultaneous positron emission tomography and 
magnetic resonance imaging (PET/MRI) depends on accurate attenuation correction. 
Simultaneous imaging with positron emission tomography and computed tomography 
(PET/CT) is the current clinical gold standard for PET attenuation correction since the CT 
images can be used for attenuation correction of 511keV photons with piecewise-linear 
models (1). Magnetic resonance imaging (MRI) measures spin density rather than 
electron density and thus cannot directly be used for PET attenuation correction. 
Current methods for attenuation correction in PET/MRI can be grouped into the 
following categories: atlas-based, segmentation-based, and machine learning. Atlas-
based methods utilize a CT atlas that is generated and registered to the acquired MRI 
(2–5). Segmentation-based methods use special sequences such as ultrashort echo-time 
(UTE) (6–10) or zero echo-time (ZTE) (11–15) to estimate bone density and Dixon 
sequences (16–18) to estimate soft tissue densities. Machine learning methods, including 
deep learning methods, use sophisticated machine learning models to learn mappings 
from MRI to pseudo-CT images (19–21). Of these, deep learning is considered a very 
promising method for accurate and precise PET/MRI attenuation correction. 
In supervised deep learning, the model training requires well-matched inputs and 
outputs. Thus, the presence of metal implants complicates training the most because the 
metal artifact appears differently in CT and in MRI; a metal implant produces a star-like 
streaking pattern with high Hounsfield unit values in the CT image (22) and a signal void 
in the MRI image (23). 
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An alternative method for attenuation correction in PET is by joint estimation, also 
known as maximum likelihood estimation of activity and attenuation (MLAA) (24). Rather 
than relying on an attenuation map that was measured or estimated with another scan or 
modality, the PET activity image (𝜆-map) and PET attenuation coefficient map (𝜇-map) 
are estimated jointly from the PET emission data only. However, MLAA suffers from 
numerous artifacts and high noise (25). In PET/MRI, recent methods to overcome the 
limitations of MLAA include constraining the region of joint estimation (26), using MR-
based priors (23), or using deep learning to denoise the resulting 𝜆-map and 𝜇-map from 
MLAA (27,28). Ahn et al and Fuin et al’s methods (23,26) were able to recover metal 
implants in the PET image reconstruction, but the images were missing bones and other 
anatomical features. Hwang et al’s method (27,28) results in anatomically correct and 
accurate 𝜇-maps; however, the method was not demonstrated in the presence of metal 
implants. 
In this work, we propose a synthesis of MLAA with deep learning-based pseudo-
CT methods. Extending the framework of Ahn et al’s MLAA regularized with MR-based 
priors (23), we generate more accurate MR-based priors with a Bayesian convolutional 
neural network (BCNN) (29) and additionally generate a weight map that guides the 
MLAA updates. We demonstrate a methodology that produces anatomically correct, 
accurate, and precise 𝜇-maps with high SNR that can recover metal implants for accurate 
and precise PET/MRI attenuation correction in the pelvis. 
 
MATERIALS AND METHODS 
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 UpCT-MLAA is composed of two major elements: initial pseudo-CT 
characterization with Bayesian deep learning through Monte Carlo Dropout and PET 
reconstruction with regularized MLAA (23). The algorithm is depicted in Figure 1 and each 
component is described in detail below. 
 
Bayesian Deep Learning 
The architecture of the BCNN is shown in Supplemental Figure 1. It was based off 
the network in (20) with the following modifications: Dropout (29,30) was included after 
every convolution, the patch size was increased to 64 × 64 × 32 voxels, and each layer’s 
number of channels was increased by 4 times to compensate for the reduction of 
information capacity due to the Dropout. The PyTorch software package (31) (v0.4.1, 
http//pytorch.org) was used. 
Inputs to the model were volume patches of the following dimensions: size 64 
pixels × 64 pixels × 32 pixels × 3 channels. Each channel was a volume patch of the 
bias-corrected and fat-tissue normalized Dixon in-phase image, Dixon fractional fat 
image, and Dixon fractional water image, respectively, at the same spatial locations (32). 
The output was a corresponding pseudo-CT image with size 64 pixels × 64 pixels × 32 
pixels × 1 channel. The model training procedure and parameters are described in the 
Supplemental Text.  
 
Pseudo-CT prior and weight map 
Generation of the pseudo-CT estimate and variance image was performed through 
Monte Carlo Dropout (29) with the BCNN described above. The Monte Carlo Dropout 
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inference is outlined in Figure 1. A total of 283 Monte Carlo samples were performed to 
generate a pseudo-CT estimate and a variance map: 
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where 𝒇𝑖 is a sample of the BCNN with Dropout, 𝒙 is the input Dixon MRI, and N is the 
number of Monte Carlo samples. Inference took approximately 40 minutes per patient on 
8 NVIDIA K80 graphics processing units. 
The pseudo-CT estimate was converted to a 𝜇-map with a bilinear model (1) and 
the variance map was converted to a weight map with a range of 0.0 to 1.0 with the 
following empirical transformation: 
𝐰(r⃗) =
1
1 + exp(0.0001𝝈2(𝑟) − 25)
 
where 𝝈2(𝑟) is the variance at voxel position 𝑟. Additional image processing is described 
in Supplemental Text. The weight map was then linearly scaled to have a range of 1 × 103 
to 5 × 106, called 𝛽𝑀𝑅. The low 𝛽𝑀𝑅 values correspond to regions with high uncertainty 
and thus the estimation for these regions would be dominated by the emission data. 
 
UpCT-MLAA 
 UpCT-MLAA is a combination of the outputs of the BCNN and regularized MLAA. 
The process is depicted in Figure 1. MRI and CT images of patients without metal 
implants were used to train the BCNN. By training only with patients without metal 
implants, the BCNN is forced to extrapolate on the voxel regions containing metal 
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implants. Thus, a high variance (>=~1 × 105 HU2) was assigned to the implant regions 
compared to a low variance in normal anatomy (0 to ~2.5 × 104 HU2) as can be seen in 
Figure 1. The 𝜇-map estimate and the weight map were then provided to the regularized 
MLAA to perform PET reconstruction (5 iterations with 28 subsets, each iteration consists 
of 1 TOF-OSEM iteration and 5 ordered subsets transmission (OSTR) iterations, 𝛽𝑀𝑅 as 
described above, 𝛽𝑠𝑚𝑜𝑜𝑡ℎ=2 × 10
4). 
 
PET reconstructions  
 In addition to UpCT-MLAA, additional PET reconstructions were performed for 
comparison.  
For each patient without metal implants, UpCT-MLAA was performed along with 
time-of-flight ordered subsets expectation maximization with a point spread function 
model (TOF-OSEM) (35) (transaxial field of view (FOV) = 600mm, 2 iterations, 28 
subsets, matrix size = 192 × 192, 89 slices of 2.78mm thickness) with two 𝜇-maps: ZeDD-
CTAC and CTAC, for comparison. 
 For each patient with metal implants, UpCT-MLAA was performed along with (1) 
standard MLAA, and (2) TOF-OSEM with ZeDD-CTAC for comparison. 
 
Patient studies 
The study was approved by the local Institutional Review Board. Patients who were 
imaged with PSMA-11 signed a written informed consent form while other patients had 
informed consent waived under our IRB protocol. A flowchart of the methodology is shown 
in Figure 2. 
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Patients with pelvic lesions were scanned using an integrated 3 Tesla time-of-flight 
PET/MRI system (36) (SIGNA PET/MR, GE Healthcare, Chicago, IL, USA). The patient 
population consisted of 29 patients (Age = 58.7 ± 13.9 years old, 16 males, 13 females):  
10 patients without implants were used for model training, 16 patients without implants 
were used for evaluation with a CT reference, and three patients with implants were used 
for evaluation in the presence of metal artifacts. Additional information about the 
evaluation dataset are summarized in Supplemental Tables 1 and 2.      
    PET/MRI Acquisition. The PET acquisition was performed with different radiotracers: 
18F-FDG (11 patients), 68Ga-PSMA-11 (7 patients), 68Ga-DOTATATE (1 patient). The 
PET scan had 600 mm transaxial field-of-view (FOV) and 25 cm axial FOV, with time-of-
flight timing resolution of approximately 400 ps. The imaging protocol included a six bed-
position whole-body PET/MRI and a dedicated pelvic PET/MRI acquisition. The PET data 
were acquired for 15 min during the dedicated pelvis acquisition, during which clinical 
MRI sequences and the following MRAC sequences were acquired: Dixon (FOV = 
500 × 500 × 312 mm, resolution = 1.95 × 1.95 mm, slice thickness = 5.2 mm, slice 
spacing = 2.6 mm, scan time = 18 s) and ZTE MR (cubical FOV = 340340340 mm, 
isotropic resolution = 222 mm, 1.36 ms readout duration, FA = 0.6°, 4 µs hard RF pulse, 
scan time = 123 s). 
    CT Imaging. Helical CT images of the patients were acquired separately on different 
machines (GE Discovery STE, GE Discovery ST, Siemens Biograph 16, Siemens 
Biograph 6, Philips Gemini TF ToF 16, Philips Gemini TF ToF 64, Siemens SOMATOM 
Definition AS) and were co-registered to the MR images using the method outlined in the 
Supplemental Text. Multiple CT protocols were used with variable parameter settings 
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(110-130 kVp, 30-494 mA, rotation time = 0.5 s, pitch = 0.6-1.375, 11.5-55 mm/rotation, 
axial FOV = 500-700 mm, slice thickness = 3-5 mm, matrix size = 512×512). Additional 
pre-processing of the CT images is described in the Supplemental Text. 
     Data Analysis. Image error analysis and lesion-based analysis were performed for 
patients without metal implants: the average (µ) and standard deviation (σ) of the error, 
mean-absolute-error (MAE), and root-mean-squared-error (RMSE) were computed over 
voxels that met a minimum signal amplitude and/or signal-to-noise criteria (20). Global 
HU and PET SUV comparisons were only performed in voxels with amplitudes > -200 HU 
in the ground-truth CT to exclude air, and a similar threshold of > 0.08 cm-1 attenuation in 
the CTAC was used for comparison of AC maps. Bone and soft-tissue lesions were 
identified by a board-certified radiologist. Bone lesions are defined as lesions inside bone 
or with lesion boundaries within 10 mm of bone (38). A Wilcoxon signed-rank test was 
used to compare the SUVmax biases compared to CTAC of individual lesions. 
 In the cases where a metal implant was present, we qualitatively examined the 
resulting AC maps of the three different reconstructions, examined the changes in SUV 
with a 2D histogram, and quantitatively compared SUVmax with a regression analysis for 
each pair of PET reconstructions. High uptake lesions and lesion-like objects were 
identified on the PET images reconstructed with UpCT-MLAA and separated into two 
categories: (1) in-plane with the metal implant, and (2) out-plane of the metal implant. For 
lesions in-plane with the metal implant, we considered standard MLAA as a reference 
since the attenuation of the PET activity would be most dominated by the metal 
attenuation. For lesions out-plane of the metal implant, we considered TOF-OSEM with 
ZeDD-CTAC as a reference.  
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RESULTS 
Monte Carlo Dropout 
Representative images of the output of the BCNN with Monte Carlo Dropout is shown in 
Figure 3. The same mask used for the weight maps was used to remove voxels outside 
the body.  
 
Patients without implants 
The PET reconstruction results for the patients without implants are summarized in Figure 
4. The RMSE is reported along with the average (𝜇) and standard deviation (𝜎) of the 
error as RMSE (𝜇 ± 𝜎).  
 
PET images. The total RMSE and MAE for PET images compared to gold-standard CTAC 
PET across all volumes were 0.025 SUV (−0.005 ± 0.025 SUV) and 0.01 ± 0.023 SUV for 
ZeDD PET and 0.027 SUV (2.00 × 10−4 ± 0.027 SUV) and 0.012 ± 0.024 SUV for UpCT-
MLAA PET. 
 
Lesion uptake and SUVmax. The results for lesion analysis for patients without implants 
are shown in Figure 4. The RMSE w.r.t CTAC PET SUVmax for all lesion voxels across 
bone lesions was 2.7 % (−1.3 ± 2.4 %) for ZeDD PET and 3.6 % (−0.3 ± 3.6 %) for UpCT-
MLAA PET. For soft tissue lesions, the RMSE was 4.4 % (−2.9 ± 3.3 %) for ZeDD PET 
and 4.7 % (−1.1 ± 4.5 %) for UpCT-MLAA PET. For SUVmax, the RMSE for bone lesions 
was 2.7 % (−1.3 ± 2.3 %) for ZeDD PET and 3.4 % (0.03 ± 3.4 %) for UpCT-MLAA PET, 
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and the RMSE for soft tissue lesions was 4.1 % (−2.3 ± 3.4 %) for ZeDD PET and 
4.8 % (−1.7 ± 4.5 %) for UpCT-MLAA PET. For SUVmax of bone lesions, ZeDD PET and 
UpCT-MLAA PET were significantly different (p = 0.037), while for SUVmax of soft tissue 
lesions, no significant difference could be found between ZeDD PET and UpCT-MLAA 
PET (p = 0.16). 
 
Patients with metal implants 
The results for the patients with metal implants are summarized in Figure 5 and Figure 6. 
 
Metal implant recovery. Figure 5 shows the different AC maps generated with the different 
reconstruction processes, PET difference images, and 2D histograms of the uptake 
comparisons.  
For the slice with the metal implant, UpCT-MLAA-AC was able to recover the metal 
implant and was constrained in the regions where high variance was measured. Although 
reconstructing using standard MLAA recovers the metal implant, the AC map was very 
noisy and anatomical structures were difficult to depict. ZeDD-CTAC filled in the location 
of the metal implant with air since the metal artifact in MRI appears as a signal void. 
UpCT-MLAA PET and standard MLAA PET has better agreement in PET uptake due to 
the recovery of the metal implant while ZeDD PET demonstrates large underestimation 
of uptake near the implant region. 
For the slice unaffected by the metal implant, the AC maps of UpCT-MLAA and 
ZeDD were qualitatively similar, and there was quantitative agreement in PET uptake. In 
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contrast, standard MLAA PET demonstrated large variance of the PET uptake compared 
to ZeDD PET. 
 
SUVmax quantification. Figure 6 shows the comparisons of SUVmax on lesions in-plane of 
the metal implant and out-plane of the metal implant. A total of 6 lesions in-plane of the 
metal implant and 15 out-plane of the metal implant were identified. Comparing UpCT-
MLAA PET and standard MLAA PET, results for in-plane lesions showed good agreement 
of SUVmax (y = 1.02x, r2 = 0.92), like the results shown in Figure 5.  However, for ZeDD 
PET and standard MLAA PET, there was underestimation of SUVmax and less agreement 
(y = 0.76x, r2 = 0.35). For lesions out-plane of the implant, UpCT-MLAA PET and ZeDD 
PET had excellent agreement (𝑦 = 1.00𝑥, r2 = 1.00), while there was slight 
overestimation and less agreement between standard MLAA PET and ZeDD PET (𝑦 =
1.04𝑥, r2 = 0.86). 
 
DISCUSSION 
This paper presents the use of a Bayesian deep convolutional neural network to 
enhance MLAA by providing an accurate pseudo-CT prior and uncertainty estimates 
(UpCT-MLAA).  The method was evaluated in patients without and with implants with 
pelvic lesions.  The performance for metal implant recovery and uptake estimation in 
pelvic lesions in patients with metal implants was characterized.  This is the first work that 
demonstrated an MLAA algorithm that was able to recover metal implants while also 
accurately depicting detailed anatomic structures in the pelvis. This is also the first work 
to synergistically combine Bayesian deep learning and MLAA in a coherent framework 
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for simultaneous PET/MRI reconstruction in the pelvis. The UpCT-MLAA method 
demonstrated similar quantitative uptake estimation of pelvic lesions to a state-of-the-art 
attenuation correction method (ZeDD-CT) while additionally providing the capability to 
perform accurate PET reconstruction in the presence of metal implants. 
One of the major advantages of using MLAA is that it uses the PET emission data 
to estimate the attenuation coefficients alongside the emission activity. This gives MLAA 
the capability to truly capture the underlying imaging conditions that the PET photons 
undergo. This is especially important in simultaneous PET/MRI where true ground-truth 
attenuation maps cannot be derived. Currently, the most successful methods for obtaining 
attenuation maps are through deep learning-based methods (19–21). However, these 
methods are inherently model-based techniques and do not capture imaging conditions 
that were not present in the training set nor conditions that cannot be reliably modeled, 
such as the movement and mismatch of bowel air and the presence of metal artifacts. 
Since MLAA derives the attenuation maps from the PET emission data, MLAA can derive 
actual imaging conditions that model-based techniques are unable to capture. This would 
allow for more accurate and precise uptake quantification in simultaneous PET/MRI. 
 To the best of our knowledge, only one other method combines MLAA with deep 
learning (27,28). Hwang et al (27,28) applies deep learning to denoise an MLAA 
reconstruction by training a deep convolutional neural network to produce an equivalent 
CTAC from MLAA estimates of activity and attenuation maps. This method inherently 
requires ground-truth CTAC maps to train the deep convolutional neural network and thus 
is affected by the same limitations that deep learning and model-based methods have.  
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Unlike their method, our method (UpCT-MLAA) preserves the underlying MLAA 
reconstruction while still providing the same reduction of crosstalk artifacts and noise. 
 A major limitation of our work is that we did not have CTAC comparisons for our 
cases with metal implants; therefore, we used MLAA as a reference substitute for these 
cases. A major challenge to evaluate PET reconstructions in the presence of metal 
implants is that typical CT protocols for CTAC produce severe metal implant artifacts and 
would be unsuitable as a reference. Furthermore, accurate co-registration of CT and MRI 
with metal implant artifacts is difficult since the artifacts present themselves differently: 
metal implants appear as a star-like streaking pattern in CT and appear as a dipolar signal 
void in MRI. A potential approach to evaluate UpCT-MLAA with gold standard CT images 
is by using metal artifact reduction techniques on the CT acquisition (22). 
 Another limitation of this study is that UpCT-MLAA was only demonstrated on three 
patient cases with metal implants. Having a larger population would allow evaluation with 
a larger variety of implant configurations. 
 Finally, the performance of the algorithm can be further improved. In this study, we 
only sought to demonstrate that the structure of the anatomy is preserved and that 
implants can be recovered while still providing similar PET uptake estimation performance 
in pelvic lesions. Since UpCT-MLAA leverages PET emission data, this provides the most 
physically relevant source for PET reconstruction. With additional tuning of the algorithm 
and optimization of the BCNN, UpCT-MLAA can produce the most accurate and precise 
attenuation coefficients in all tissues and in any imaging conditions. 
 
CONCLUSION 
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 We have developed and evaluated an algorithm that utilizes a Bayesian deep 
convolutional neural network that provides accurate pseudo-CT priors with uncertainty 
estimation to enhance MLAA PET reconstruction. We demonstrated quantitative 
accuracy in pelvic lesions and robust recovery of metal implants in pelvis PET/MRI. 
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KEY POINTS 
QUESTION:  
Can we do accurate and precise PET attenuation correction in simultaneous PET/MRI of 
the pelvis in patients with metal implants? 
PERTINENT FINDINGS:  
Bayesian deep learning provides an initial pseudo-CT estimate and an uncertainty map 
that can be synergistically combined with regularized MLAA to effectively estimate activity 
and attenuation particularly in “uncertain” regions (e.g. near metal implants). UpCT-MLAA 
successfully estimated the attenuation coefficients of the metal implants while still 
providing qualitatively and quantitatively accurate anatomic depiction outside of metal 
implant regions to provide accurate and precise PET activity estimates. 
IMPLICATIONS FOR PATIENT CARE:  
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These findings allow accurate and precise PET/MRI of the pelvis in patients with metal 
implants. 
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Figure 1. Schematic flow of UpCT-MLAA. Monte Carlo Dropout is first performed with the 
BCNN, then the outputs are provided as inputs to PET reconstruction with regularized 
MLAA. The network architecture is shown in Supplemental Figure 1. 
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Figure 2. Flowcharts demonstrating the process and comparisons for patients without 
metal implants (left) and patients with metal implants (right). 
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Figure 3. Representative intermediate image outputs of the BCNN with Monte Carlo 
Dropout. The voxel-wise standard deviation map is shown instead of variance for better 
visual depiction. Regions with high standard deviation correspond to bone, bowel air, skin 
boundary, implants, and regions with likely modeling error (e.g. around the bladder in the 
standard deviation map in rightmost column). 
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Figure 4. Representative images of bone and soft tissue lesions (A, reproduced from 
(20)), scatter plots of SUV in every lesion voxel (B), and box plots of the SUVmax in each 
lesion (C). This shows that UpCT-MLAA-AC is near equivalent to ZeDD-CTAC in patients 
without implants when comparing to CTAC. 
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Figure 5. Representative results from one patient for a slice in-plane to a metal implant 
(A-D) and a slice out-plane to a metal implant (E-H). Attenuation coefficient maps (A, E), 
PET images (B, F), PET difference images (C, G) and 2D histograms (D, H). The yellow 
arrows point to high uptake lesions. 
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Figure 6. Scatter plots (left) and Bland-Altman plots (right) of lesion SUVmax for lesions 
in-plane (A) and out-plane (B) of the metal implant. The solid line and the dashed line 
bounds on the Bland-Altman plot show the mean difference and the ±1.45 Interquartile 
Range (IQR), respectively. 
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Supplemental Information to Bayesian deep learning Uncertainty estimation and 
pseudo-CT prior for robust Maximum Likelihood estimation of Activity and 
Attenuation (UpCT-MLAA) in the presence of metal implants for simultaneous 
PET/MRI in the pelvis (A.P. Leynes et al) 
 
Bayesian Deep Learning Model Training  
Model training was performed similarly to our previous work (1,2). The loss function was 
a combination of an L1-loss, gradient difference loss (GDL), and Laplacian difference loss 
(LDL): 
𝐿𝑜𝑠𝑠 = |𝒚 − ?̂?| + 𝜆𝐺𝐷𝐿 (|∇x𝒚 − ∇x?̂?|
2 + |∇y𝒚 − ∇y?̂?|
2
+ |∇z𝒚 − ∇z?̂?|
2) + 𝜆𝐿𝐷𝐿(|Δ𝒚 − Δ?̂?|
2) 
where ∇ is the gradient operator, Δ is the Laplacian operator, 𝒚 is the ground-truth 
CT image patch, and ?̂? is the output pseudo-CT image patch with 𝜆𝐺𝐷𝐿 = 0.01 and 𝜆𝐿𝐷𝐿 =
0.01. The Adam optimizer (3) (learning rate = 1 × 10−5, 𝛽1 = 0.9, 𝛽2 = 0.999, 𝜖 =
1 × 10−8 ) was used to train the neural network. An L2 regularization (𝜆 = 1 × 10−5) on 
the weights of the network was used. He initialization (4) was used and a mini-batch of 4 
volumetric patches was used for training on two NVIDIA GTX Titan X Pascal (NVIDIA 
Corporation, Santa Clara, CA, USA) graphics processing units. The models were trained 
for approximately 68 hours to achieve 100,000 iterations. 
 
Weight Map Image Processing 
The weight map was additionally processed to set weights outside the body (e.g. air 
voxels) to 0.0 so that these were not included in MLAA reconstruction. A body mask 
was generated by thresholding (> -400 HU) the pseudo-CT estimate. The initial body 
mask was morphologically eroded by a 1-voxel radius sphere. Holes in the body were 
then filled in with the imfill function (Image Processing Toolbox, MATLAB 2014b) at 
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each axial slice. The body masks were then further refined by removing arms as in our 
previous work (5). 
 
CT image pre-processing for patient studies 
Pre-processing consisted of filling in bowel air with soft-tissue HU values and copying 
arms from the Dixon-derived pseudoCT due to the differences in bowel air distribution 
and the CT scan being acquired with arms up, respectively (5). 
 
MRI and CT image registration  
MRI and CT image pairs were co-registered using the ANTS (6) registration package and 
the SyN diffeomorphic deformation model with combined mutual information and cross-
correlation metrics (1,2,5). 
 
Attenuation coefficient map results  
The total RMSE and MAE for the AC maps compared to gold-standard CTAC across all 
volumes were 3.6 × 10−3 cm−1 (−7.2 × 10−4 ± 3.6 × 10−3 cm−1), and 2.2 × 10−3 ± 2.9 ×
10−3 for ZeDD-CTAC and 3.9 × 10−3 cm−1 (−2.1 × 10−5 ± 3.9 × 10−3 cm−1) and 2.5 ×
10−3 ± 2.9 × 10−3 cm−1 for UpCT-MLAA-AC.  
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Supplemental Figure 1. Deep convolutional neural network architecture used in this 
work. Highlighted with the colored text are the major changes to compensate for the 
Dropout. 
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Supplemental Figure 2. Representative attenuation coefficient map results for patients 
without metal implants. CT-based attenuation coefficient map (CTAC) (A), difference 
images of ZeDD-CTAC and UpCT-MLAA-AC with CTAC (B), and 2D histograms (C). This 
shows that ZeDD-CTAC is near equivalent to UpCT-MLAA-AC in patients without 
implants when comparing to CTAC.  
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Supplemental Table 1. Patient demographics, disease diagnoses, and PET 
radiotracers of patients without implants. 
Patient # Age Gender Disease Radiotracer 
1 56 Male Lung cancer with bone metastases 18F-FDG 
2 59 Female Colon cancer 18F-FDG 
3 60 Male Colon cancer 18F-FDG 
4 56 Male Rectal cancer 18F-FDG 
5 58 Male Rectal cancer 18F-FDG 
6 58 Female Rectal cancer 18F-FDG 
7 54 Female Rectal cancer 18F-FDG 
8 69 Male Prostate cancer 68Ga-PSMA-11 
9 70 Male Prostate cancer 68Ga-PSMA-11 
10 60 Female Cervical cancer 18F-FDG 
11 83 Male Prostate cancer 68Ga-PSMA-11 
12 62 Male Prostate cancer 68Ga-PSMA-11 
13 51 Female Ovarian cancer 18F-FDG 
14 62 Male Rectal Cancer 18F-FDG 
15 78 Male Prostate cancer 68Ga-PSMA-11 
16 53 Male Prostate cancer 68Ga-PSMA-11 
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Supplemental Table 2. Patient demographics, disease diagnoses, implant type and 
location, and PET radiotracers of patients with implants. 
Patient # Age Gender Disease Implant Radiotracer 
1 51 Male Prostate cancer Left hip implant 68Ga-PSMA-11 
2 73 Female Neuroendocrine cancer Left hip implant 68Ga-DOTATATE 
3 69 Female Cervical cancer Right hip implant 18F-FDG 
 
 
 
 
